| 000 | 01697 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517130458.0 | ||
| 264 | 0 | _c20170410 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2016.04.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerola, J | |
| 245 | 0 | 0 |
_aBelatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cNov 2016 |
||
| 300 |
_a3106-3108 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAbatacept _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAtypical Hemolytic Uremic Syndrome _xcomplications |
| 650 | 0 | 4 |
_aCalcineurin Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlasmapheresis _xadverse effects |
| 650 | 0 | 4 |
_aPostoperative Complications _xchemically induced |
| 650 | 0 | 4 |
_aThrombotic Microangiopathies _xchemically induced |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aYoo, P S | |
| 700 | 1 | _aSchaub, J | |
| 700 | 1 | _aSmith, J D | |
| 700 | 1 | _aRodriguez-Davalos, M I | |
| 700 | 1 | _aTichy, E | |
| 700 | 1 | _aMulligan, D C | |
| 700 | 1 | _aAsch, W | |
| 700 | 1 | _aFormica, R | |
| 700 | 1 | _aKashgarian, M | |
| 700 | 1 | _aKulkarni, S | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 48 _gno. 9 _gp. 3106-3108 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2016.04.005 _zAvailable from publisher's website |
| 999 |
_c26678938 _d26678938 |
||